Ameriprise Financial Inc Sc Pharmaceuticals Inc. Transaction History

Ameriprise Financial Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$4.86 - $6.39 $9,763 - $12,837	-2,009 Reduced 2.29%	85,863 $431,000
Q4 2023 Feb 14, 2024	SELL	$4.7 - $6.63 $59,816 - $84,380	-12,727 Reduced 12.65%	87,872 $550,000
Q3 2023 Nov 14, 2023	SELL	$7.0 - $9.82 $6,258 - $8,779	-894 Reduced 0.88%	100,599 $716,000
Q2 2023 Aug 14, 2023	BUY	$8.94 - $11.74 $43,770 - $57,479	4,896 Added 5.07%	101,493 $1.03 Million
Q1 2023 May 15, 2023	BUY	$5.59 - $9.47 $539,977 - $914,773	96,597 New	96,597 $876,000

37.1M

110K

12.1K

Ticker SCPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,402,100
Market Cap $92.9M
Description
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.